JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312075

Alexa Fluor® 555 Anti-DYNLL1 / PIN antibody [EP1660Y]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal DYNLL1/PIN antibody - conjugated to Alexa Fluor® 555.

View Alternative Names

DLC1, DNCL1, DNCLC1, HDLC1, DYNLL1, 8 kDa dynein light chain, Dynein light chain LC8-type 1, Protein inhibitor of neuronal nitric oxide synthase, DLC8, PIN

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-DYNLL1/PIN antibody [EP1660Y]

  • 578 PE

    PE Anti-DYNLL1 / PIN antibody [EP1660Y]

  • 660 APC

    APC Anti-DYNLL1 / PIN antibody [EP1660Y]

  • HRP

    HRP Anti-DYNLL1 / PIN antibody [EP1660Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-DYNLL1 / PIN antibody [EP1660Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-DYNLL1 / PIN antibody [EP1660Y]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-DYNLL1 / PIN antibody [EP1660Y]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-DYNLL1/PIN antibody [EP1660Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1660Y

Isotype

IgG

Conjugation

Alexa Fluor® 555

Excitation/Emission

Ex: 555nm, Em: 565nm

Carrier free

No

Applications

Antibody Labelling, Target Binding Affinity

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

ab51603 recognizes DLC8.The mouse and rat recommendation is based on the WB results. We do not guarantee IHC-P for mouse and rat.

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function (By similarity). Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules (By similarity). May play a role in changing or maintaining the spatial distribution of cytoskeletal structures (By similarity). In addition to its role in cytoskeleton and transport, acts as a protein-protein adapter, which inhibits and/or sequesters target proteins (PubMed : 10198631, PubMed : 15193260, PubMed : 15891768, PubMed : 16684779, PubMed : 30464262, PubMed : 37696958). Involved in the response to DNA damage by acting as a key regulator of DNA end resection : when phosphorylated at Ser-88, recruited to DNA double-strand breaks (DSBs) by TP53BP1 and acts by disrupting MRE11 dimerization, thereby inhibiting DNA end resection (PubMed : 30464262, PubMed : 37696958). In a subset of DSBs, DYNLL1 remains unphosphorylated and promotes the recruitment of the Shieldin complex (PubMed : 37696958). Binds and inhibits the catalytic activity of neuronal nitric oxide synthase/NOS1 (By similarity). Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1 (PubMed : 15891768, PubMed : 16684779). Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules (PubMed : 10198631, PubMed : 15193260). Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity (PubMed : 10198631, PubMed : 15193260).
See full target information DYNLL1

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com